Approved for Long-term maintenance treatment of airflow obstruction in patients with COPD. Combines glycopyrrolate (LAMA) and formoterol (LABA). Glycopyrrolate blocks M3 muscarinic receptors while formoterol stimulates beta-2 receptors, providing dual bronchodilation through complementary… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA…
Loading full data from Know Your Drugs Institute…